Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German doctors call on Bundesrat to stop DRGs (diagnosis related groups:

This article was originally published in Clinica

Executive Summary

The German association of hospital-based doctors and staff, the Marburger Bund, has called on the Upper House (Bundesrat) to block the diagnosis related groups (DRG) system bill at its plenary sitting at the end of January. The association claims that the bill to reform hospital reimbursement will intensify the problem of unpaid overtime in hospitals it aims to ensure that more patients are treated in a shorter period of time. Marburger Bund chairman Dr Frank-Ulrich Montgomery said: "Health minister Ulla Schmidt and Employment minister Walter Riester have decided to close their ears to the theme of overtaxed doctors. It now remains with the Bundesrat, as the only political means of putting a speedy end to this undignified chapter of German hospital policy."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel